United States
Germany
Japan
United Kingdom
China
AAV8 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
Others
AAV-PHP.eB with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
First Strand cDNA Human Prostate (30 rxns)
First Strand cDNA Human Liver (30 rxns)
First Strand cDNA Human Leukocyte (30 rxns)
AAV1 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
AAV9 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
First Strand cDNA Mouse Brain (30 rxns)
First Strand cDNA Human Set 2 (Small Intestine, Muscle, Lung, Prostate, Testis, Ovary (10 rxns each)
Protein A Sepharose®
AAVDJ with CMV promoter-driven expression of GFP, >10^13 GC/mL, 1 x 100 uL
AAV1 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 1 x 100 uL
AAVrh.10-CMV-GFP Control Particle, 1 x 100 uL
AAV2 control particles, shRNA scramble, expressing GFP and puro, >10^13 GC/mL, 1 x 100 uL
AAV5 with CMV promoter-driven expression of GFP, >10^13 GC/mL, 50 ul
